ADVB
Advanced Biomed Inc. Common Stock
NASDAQ: ADVB · HEALTHCARE · DIAGNOSTICS & RESEARCH
$5.30
+0.00% today
Updated 2026-04-29
Market cap
$7.23M
P/E ratio
1.51
P/S ratio
—
EPS (TTM)
$3.52
Dividend yield
—
52W range
$4 – $49
Volume
0.7M
Advanced Biomed Inc. Common Stock (ADVB) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating cash flow | $-473975.00 | $-741450.00 | $-2.96M | $-2.13M | $-181464.00 |
| Capital expenditures | $25442.00 | $1.31M | $212523.00 | $74110.00 | $985.00 |
| Depreciation | — | — | — | — | — |
| Stock-based comp | — | — | — | — | — |
| Free cash flow | $-499417.00 | $-2.05M | $-3.18M | $-2.20M | $-182449.00 |
| Investing cash flow | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — |
| Dividends paid | — | — | — | — | — |
| Share repurchases | — | — | — | — | — |
| Debt repayment | — | — | — | — | — |
| Net change in cash | — | — | — | — | — |